Avita Medical (RCEL) Financials: Revenue & Earnings

RCEL price $16.42 +0.34 +2.09%

Ticker
RCEL
Price
$16.42
Change
+0.34 +2.09%
Market cap ?
$407.80M
Beta ?
1.99
Sector
Healthcare
Industry
Medical - Devices

Fair value

RCEL fair value $8.04. Price $16.42. Price is 104% above fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 14.52M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 2.0). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 24.84M. Net debt 35.80M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare RCEL

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.24—22.35M
2026-08-06-0.25-0.2921.49M20.25M
2026-05-14-0.35-0.3519.25M18.30M
2026-02-12-0.38-0.3617.43M17.84M
2025-11-06-0.46-0.4317.06M26.86M
2025-08-07-0.38-0.2612.03M40.22M
2025-05-08-0.53-0.3911.63M37.36M
2025-02-13-0.44-0.3011.39M31.59M
2024-11-07-0.62-0.4213.52M35.37M
2024-08-08-0.60-0.5910.13M14.73M
2024-05-13-0.73-0.267.21M11.05M
2024-02-22-0.28-0.349.66M14.50M
2023-11-09-0.34-0.5313.58M13.37M
2023-08-10-0.41-0.3411.72M11.32M
2023-05-11-0.37-0.227.08M11.32M
2023-02-23-0.21-0.326.46M10.33M
2022-11-10-0.22-0.329.21M7.48M
2022-08-11-0.25-0.358.30M7.32M
2022-05-12-0.38-0.367.54M7.24M
2022-02-28-0.34-0.436.94M30.00M
2021-11-08-0.24-0.407.02M7.00M
2021-08-26-0.19-0.3210.30M8.28M
2021-05-13-0.26-0.308.77M9.93M
2021-02-11-0.26-0.485.08M7.12M
2020-11-10-0.48-0.255.06M105.94M
2020-08-27-0.60-0.243.89M5.71M
2020-04-30-0.71—3.83M—
2020-02-18-0.53-0.033.27M—
2019-10-31-0.22—1.46M—
2019-09-30-0.19—3.24M—
2019-03-31-0.22—1.49M—
2019-02-27-0.43—493.80K—
2018-10-30-0.42—473.52K—
2018-06-30-0.27—192.02K—
2018-04-29-0.25—174.22K—
2018-01-31-0.27—182.65K—
2017-10-29-0.28—187.01K—
2017-08-28-0.27—193.82K—
2017-04-28-0.27—192.24K—
2017-01-30-0.21—135.56K—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-06-12O'Toole David DBuy2.00K$3.977.94K
2026-06-12O'Toole David DBuy2.00K$3.977.94K
2026-06-09Woody Joseph FralinBuy5.20K$4.0020.80K
2026-06-09Woody Joseph FralinBuy5.00K$4.1820.90K
2026-06-09Woody Joseph FralinBuy5.00K$4.2021.00K
2026-06-03Woody Joseph FralinBuy5.00K$4.0920.45K
2026-06-03Woody Joseph FralinBuy5.00K$4.1020.50K
2026-05-29O'Toole David DBuy5.00K$3.0515.26K
2026-05-29Vance Cary GuyBuy5.00K$3.0515.26K
2026-05-20O'Toole David DBuy2.00K$4.268.52K
2026-05-19O'Toole David DBuy2.00K$4.248.48K
2026-03-11O'Toole David DBuy1.80K$4.788.60K
2026-02-19O'Toole David DBuy3.00K$4.1512.45K
2026-02-18O'Toole David DBuy155.51K$4.31670.25K
2026-02-18O'Toole David DBuy105.47K——
2026-02-18KELSEY NICOLEBuy145.06K$4.31625.21K
2026-02-18KELSEY NICOLEBuy98.39K——
2026-01-20McNamara RobertBuy22.21K——
2026-01-20McNamara RobertBuy16.13K$3.7760.82K
2026-01-20Woody Joseph FralinBuy22.21K——
2026-01-20Woody Joseph FralinBuy16.13K$3.7760.82K
2026-01-20Tarnoff Michael EBuy22.21K——
2026-01-20Tarnoff Michael EBuy16.13K$3.7760.82K
2026-01-20COOK JEREMY CURNOCKBuy22.21K——
2026-01-20COOK JEREMY CURNOCKBuy16.13K$3.7760.82K
2026-01-20Crowe SuzanneBuy22.21K——
2026-01-20Crowe SuzanneBuy16.13K$3.7760.82K
2026-01-20REED JAN STERNBuy22.21K——
2026-01-20REED JAN STERNBuy16.13K$3.7760.82K
2026-01-05Woody Joseph FralinBuy40.55K——
2026-01-05Woody Joseph FralinBuy29.45K$3.47102.18K
2026-01-01Woody Joseph FralinOther0——
2025-08-28McNamara RobertBuy10.00K$4.5045.00K
2025-08-26O'Toole David DBuy2.00K$4.529.04K
2025-08-19McNamara RobertBuy10.00K$5.0050.00K
2025-08-12O'Toole David DBuy2.00K$4.819.62K
2025-08-06Tarnoff Michael EBuy26.25K——
2025-08-06Tarnoff Michael EBuy19.06K$5.36102.18K
2025-08-06Tarnoff Michael EOther0——
2025-05-30O'Toole David DBuy1.92K$4.789.19K
2025-03-06McNamara RobertBuy11.00K$8.3091.30K
2025-02-20McNamara RobertBuy10.00K$10.09100.90K
2025-02-20O'Toole David DBuy1.00K$9.909.90K
2025-02-19O'Toole David DBuy1.00K$10.2510.25K
2025-01-21Vance Cary GuyBuy10.02K——
2025-01-21Vance Cary GuyBuy4.29K$8.7337.50K
2025-01-21REED JAN STERNBuy10.02K——
2025-01-21REED JAN STERNBuy4.29K$8.7337.50K
2025-01-21McNamara RobertBuy10.02K——
2025-01-21McNamara RobertBuy4.29K$8.7337.50K
2025-01-21COOK JEREMY CURNOCKBuy10.02K——
2025-01-21COOK JEREMY CURNOCKBuy4.29K$8.7337.50K
2025-01-21Crowe SuzanneBuy10.02K——
2025-01-21Crowe SuzanneBuy4.29K$8.7337.50K
2025-01-21Panaccio LouBuy10.02K——
2025-01-21Panaccio LouBuy4.29K$8.7337.50K
2025-01-21CORBETT JAMESBuy520.00K$8.734.54M
2025-01-21O'Toole David DBuy150.00K$8.731.31M
2025-01-21KELSEY NICOLEBuy65.00K$8.73567.45K
2024-12-09Crowe SuzanneBuy486$13.156.39K
2024-12-05O'Toole David DBuy500$12.406.20K
2024-12-05O'Toole David DBuy475$12.535.95K
2024-11-29O'Toole David DBuy785$7.836.15K
2024-08-19McNamara RobertBuy10.00K$9.0090.00K
2024-07-01KELSEY NICOLESell150.00K$7.721.16M
2024-06-05Panaccio LouBuy9.20K——
2024-06-05Panaccio LouBuy3.94K$9.5137.50K
2024-06-05Crowe SuzanneBuy9.20K——
2024-06-05Crowe SuzanneBuy3.94K$9.5137.50K
2024-06-05COOK JEREMY CURNOCKBuy9.20K——
2024-06-05COOK JEREMY CURNOCKBuy3.94K$9.5137.50K
2024-06-05REED JAN STERNBuy9.20K——
2024-06-05REED JAN STERNBuy3.94K$9.5137.50K
2024-06-05McNamara RobertBuy9.20K——
2024-06-05McNamara RobertBuy3.94K$9.5137.50K
2024-06-05Vance Cary GuyBuy9.20K——
2024-06-05Vance Cary GuyBuy3.94K$9.5137.50K
2024-06-05CORBETT JAMESBuy350.00K$12.644.42M
2024-05-31Shiroma DonnaBuy2.23K$8.1718.17K
2024-05-31O'Toole David DBuy2.24K$8.1718.30K
2024-05-30O'Toole David DBuy500$8.604.30K
2024-05-30O'Toole David DBuy500$9.204.60K
2024-02-28O'Toole David DBuy250$17.434.36K
2024-02-28O'Toole David DBuy1.00K$17.3817.38K
2024-01-03Shiroma DonnaBuy100.00K$12.641.26M
2024-01-03O'Toole David DBuy125.00K$12.641.58M
2023-12-26CORBETT JAMESSell1.45K$13.2919.20K
2023-12-21COOK JEREMY CURNOCKSell2.50K$12.4931.23K
2023-12-13COOK JEREMY CURNOCKSell2.52K$12.2730.90K
2023-12-12O'Toole David DBuy950$12.4511.83K
2023-12-01O'Toole David DBuy500$10.685.34K
2023-11-30Shiroma DonnaBuy1.47K$9.0613.31K
2023-11-30O'Toole David DBuy1.03K$9.069.37K
2023-11-21O'Toole David DBuy1.00K$10.2610.26K
2023-11-21O'Toole David DBuy1.00K$10.3010.30K
2023-11-16O'Toole David DBuy1.00K$12.1512.15K
2023-11-15O'Toole David DBuy1.00K$12.4512.45K
2023-11-15O'Toole David DBuy1.00K$13.2513.25K
2023-11-14O'Toole David DBuy1.00K$12.8812.88K
2023-08-21Shiroma DonnaSell4.19K$15.8466.42K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 78, holders -2 vs prior quarter. Ownership 16.08%.

HolderSharesChangeChange %Value
VANGUARD CAPITAL MANAGEMENT LLC1.33M-1.24K-0.09%5.51M
BLACKROCK, INC.564.95K-568.17K-50.14%2.33M
GEODE CAPITAL MANAGEMENT, LLC339.82K-203.15K-37.41%1.40M
MARSHALL WACE, LLP338.39K285.82K+543.79%1.40M
AQR CAPITAL MANAGEMENT LLC321.01K226.65K+240.20%1.33M
MORGAN STANLEY200.46K42.84K+27.18%827.91K
VANGUARD FIDUCIARY TRUST CO182.40K-11.03K-5.70%753.32K
NEWEDGE ADVISORS, LLC148.93K62.05K+71.41%615.09K
MACQUARIE GROUP LTD144.16K132.26K+1111.26%595.39K
STATE STREET CORP128.98K-300.05K-69.94%532.67K
QUANTINNO CAPITAL MANAGEMENT LP105.25K82.77K+368.12%434.67K
DIVISADERO STREET CAPITAL MANAGEMENT, LP100.00K00.00%413.00K
UBS GROUP AG84.03K21.58K+34.55%347.06K
GOLDMAN SACHS GROUP INC76.74K-23.11K-23.14%316.92K
NORTHERN TRUST CORP68.97K-114.21K-62.35%284.86K
QUBE RESEARCH & TECHNOLOGIES LTD63.78K63.78KNew263.43K
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP60.75K60.75KNew250.88K
XTX TOPCO LTD57.16K57.16KNew236.07K
BNP PARIBAS FINANCIAL MARKETS53.96K50.79K+1603.76%222.85K
BANK OF AMERICA CORP /DE/51.67K-10.46K-16.84%213.38K
FMR LLC32.52K3.88K+13.55%134.29K
IEQ CAPITAL, LLC32.40K32.40KNew133.81K
THOMPSON DAVIS & CO., INC.31.09K-7.96K-20.38%128.40K
JAIN GLOBAL LLC30.77K30.77KNew127.10K
AMERIPRISE FINANCIAL INC29.01K259+0.90%119.82K

Earnings and financials

Avita Medical Inc. (RCEL) trades at $16.42, with a market cap of $407.80M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Avita Medical (RCEL) Financials: Revenue & Earnings

RCEL$16.42+0.34 +2.09%

$407.80M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History